Background: Severe COPD can lead to cor pulmonale and emphysema and is associated with impaired left ventricular (LV) fi lling. We evaluated whether emphysema and airfl ow obstruction would be associated with changes in right ventricular (RV) structure and function and whether these associations would differ by smoking status. Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) performed cardiac MRI on 5,098 participants without clinical cardiovascular disease aged 45 to 84 years. RV and emphysema measures were available for 4,188 participants. Percent emphysema was defi ned as the percentage of voxels below 2 910 Hounsfi eld units in the lung windows on cardiac CT scans. Generalized additive models were used to control for confounders and adjust for respective LV parameters. Results: Participants consisted of 13% current smokers, 36% former smokers, and 52% never smokers . Percent emphysema was inversely associated with RV end-diastolic volume, stroke volume, cardiac output, and mass prior to adjustment for LV measures. After adjustment for LV end-diastolic volume, greater percent emphysema was associated with greater RV end-diastolic volume ( 1 1.5 mL, P 5 .03) among current smokers, smaller RV end-diastolic volume ( 2 0.8 mL, P 5 .02) among former smokers, and similar changes among never smokers. Conclusions: Percent emphysema was associated with smaller RV volumes and lower mass. The relationship of emphysema to cardiac function is complex but likely involves increased pulmonary vascular resistance, predominantly with reduced cardiac output, pulmonary hyperinfl ation, and accelerated cardiopulmonary aging. 
C hronic lower respiratory disease, which encompasses emphysema and COPD, is the third-leading cause of death in the United States. 1 Emphysema is characterized by the destruction of alveolar walls and the permanent enlargement of air spaces distal to the terminal bronchioles. 2 COPD is defi ned by a reduction in the FEV 1 /FVC ratio that is incompletely reversible to bronchodilators. 3 COPD is characterized by increased pulmonary artery pressure either at rest or with exercise. 4, 5 A subset of patients with COPD have increased pulmonary arteriovenous pressure gradient, right ventricular (RV) enlargement (termed cor pulmonale), and RV failure, classically in association with gas trapping and bronchitis. 5, 6 Other (and currently most) patients with very severe COPD do not develop cor pulmonale or RV failure but still have reduced cardiac output. This latter group classically has emphysema. 7 Although the RV changes in response to severe lung disease are reasonably well described, the impact of milder and subclinical emphysema and airfl ow obstruction on the right ventricle is less clear. We observed previously that emphysema on CT scan and airfl ow obstruction on spirometry were associated with significant decrements in left ventricular (LV) fi lling, stroke volume, and cardiac output, particularly in cigarette progression of subclinical cardiovascular diseases in whites, blacks , Hispanics, and Asians. 9 Between 2000 and 2002, MESA recruited 6,814 participants who were 45 to 84 years of age, did not report clinical cardiovascular disease, weighed , 136 kg (300 lb), and had no impediment to long-term participation. Written informed consent was obtained from all participants. The protocols of MESA were approved by the institutional review boards of all collaborating institutions and by the National Heart, Lung, and Blood Institute (e-Appendix 1).
Measurements of RV Structure and Function
The MESA-Right Ventricle Study measured RV morphology in 4,204 MESA participants with interpretable cardiac MRIs at the baseline examination ( Fig 1 ) . The protocol, its reliability, and the characteristics of MESA participants with MRI measurements have been described previously (e-Appendix 2). 10 
Assessment of Emphysema
The MESA-Lung Study quantitatively assessed the extent of emphysema on the lung fi elds of all baseline MESA cardiac CT scans, which included approximately 70% of the lung volume from the carina to the lung bases. Cardiac CT scans were obtained at full inspiration on multidetector and electron-beam CT scanners according to a standardized protocol. 11 Two scans were obtained for each participant, and the scan with the greater volume of lung air was used for analyses, except in cases of discordant scan quality, when the higher-quality scan was analyzed (e-Appendix 2). 12 
Spirometry
The MESA Lung Study performed spirometry between 2004 and 2006 in a subset of MESA participants. Spirometry was performed in accordance with the American Thoracic Society-European Respiratory Society recommended guidelines 13 (e-Appendix 2).
Smoking Status and Other Covariates
Age, sex, race or ethnic group, educational level, cigarettes smoked per day, number of pack-years of smoking, and medical history were self-reported. Height, weight, resting BP, serum glucose level, C-reactive protein level, and fi brinogen level were mea sured using standard techniques. 14 A history of hypertension or diabetes and the use of insulin or hypoglycemic or antihypertensive agents were determined. Study participants who reported having smoked at least one cigarette in the 30 days before the CT scan examination or who had a urinary cotinine level . 100 ng/mL on the day of the CT scan examination were classifi ed as current smokers.
Statistical Analysis
The data are presented as the mean Ϯ SD for continuous variables and as percentages for discrete variables for all participants and are stratifi ed by smoking status. Effect modifi cation of the relationship of pulmonary measures with RV measures by smoking status was anticipated a priori 8 and was tested with the 2 2 loglikelihood test of nested models with and without interaction terms.
We used generalized additive models to regress RV end-diastolic volume, stroke volume, ejection fraction, and mass on percent emphysema stratifi ed by smoking status and on the FEV 1 /FVC ratio. The fi rst model was adjusted for age, race or ethnicity, sex, height and weight, cigarettes smoked per day, number of packyears of smoking, serum glucose, diabetes, systolic and diastolic smokers, in a large, population-based study. 8 Whether these changes are accompanied by an increase in pulmonary arteriovenous pressure gradient with increased RV volumes and mass or, alternatively, reduced cardiac output with reduced RV dimensions is unknown.
We, therefore, examined the relationships between the percent emphysema on CT scan and airfl ow obstruction on spirometry and RV structure and function on MRI in a large population-based cohort. We fi rst examined associations of lung measures with the right ventricle unadjusted for LV measures. We then evaluated associations of lung measures and the right ventricle adjusted for LV measures because an increased pulmonary arteriovenous pressure gradient should exert a differential effect on the right ventricle and the left ventricle. We used two-tailed P values to provide a valid statistical test of either possibility. Given prior fi ndings of effect modifi cation of emphysema-LV associations by smoking status, 8 we tested for similar effect modifi cation for the right ventricle.
Material and Methods

Study Participants
The Multi-Ethnic Study of Atherosclerosis (MESA) is a multicenter, prospective cohort study of the prevalence, correlates, and Manuscript received July 17, 2012; revision accepted January 2, 2013. Affi liations: From the Department of Medicine (Drs Grau and Barr), the Department of Epidemiology (Dr Barr), and the Department of Radiology (Dr Prince), Columbia University Medical Center, New York, NY; the Department of Medicine (Drs Lima, Chahal, and Jain), Johns Hopkins University, Baltimore, MD; NationalBP, hypertension, educational attainment, serum glucose level, C-reactive protein level, and fi brinogen level. Analysis of percent emphysema was further adjusted for CT scanner type and tube current in milliamperes, which affect attenuation. Corresponding LV parameters were then added (except for stroke volume because of the interrelatedness of the variables).
Sensitivity analyses were conducted using percent emphysema in lung cores, peels, and upper-lobe regions as independent variables, stratifying by pack-years of smoking instead of smoking status and in the subsample of individuals with no restrictive ventilatory defect on spirometry . The test of the primary hypothesis, 95% CIs, and P values were estimated from generalized additive models. A two-tailed P value , .05 was considered to indicate statistical signifi cance. Analyses were performed using R statistical software, version 2.13.0 (R Foundation for Statistical Computing).
Results
Of the 6,814 MESA participants, 5,098 underwent cardiac MRI examination, of whom 5,004 had interpretable LV measures; 4,634 were selected for RV interpretation, and 4,204 were completed ( Fig 1 ) . Three were missing CT scans, and 13 were missing information on covariates, resulting in a sample size The mean age of the study sample was 61 years, and 47% were men ( Table 1 , e- Table 1 ). One-half were never smokers, 36% had smoked in the past, and 13% were current smokers. Mean spirometric measurements and RV parameters are shown in Table 2 and e- Table 2 . The median value for percent emphysema was 18.4%.
Emphysema and RV Function
Percent emphysema was inversely associated with RV end-diastolic volume, stroke volume, cardiac output, and mass in the main multivariable models (all P , .001). However, there were signifi cant interactions between RV end-diastolic volume and smoking status and percent emphysema ( P 5 .012 for interaction); hence, analyses for percent emphysema were stratifi ed by smoking status.
Greater percent emphysema was associated with smaller RV end-diastolic volume after adjustment for covariates in current, former, and never smokers ( Table 3 ). The magnitude of this association was greater among current and former smokers compared with never smokers. Generalized additive models did not reveal a nonlinear component of the relationships ( Fig 2 ) .
Greater percent emphysema was also associated with smaller RV stroke volume, irrespective of smoking status, and lower RV mass in adjusted models ( Table 3 ). These fi ndings were statistically signifi cant, except for RV mass among current smokers. Percent emphysema was inversely associated with cardiac output among never smokers, but there was no evidence of an association with RV ejection fraction or cardiac output in current smokers. Data are presented as mean Ϯ SD unless indicated otherwise. RV 5 right ventricular. See Table 1 legend for expansion of other abbreviations. a n 5 313, 951, and 1,485 for current, former, and never smokers, respectively .
After additional adjustment for respective LV measures, greater percent emphysema was associated with larger RV end-diastolic volume and greater RV cardiac output among current smokers ( Fig 3 , Table 4 ). Among former smokers, percent emphysema was associated with smaller RV end-diastolic volume and greater RV cardiac output after adjustment for LV measures. Among never smokers, there was no evidence of an association between percent emphysema and RV enddiastolic volume or RV cardiac output after adjustment for LV measures. Greater percent emphysema was also weakly associated with RV ejection fraction in former smokers and with lower RV mass among former and never smokers after adjustment for respective LV measures ( Table 4 ) .
Airfl ow Obstruction and RV Function
There was no evidence of interactions between RV parameters and spirometry by smoking status; therefore, these analyses were not stratifi ed by smoking status ( Table 5 ). Lower FEV 1 /FVC ratio was associated with lower RV mass after adjustment for LV mass. There were no other associations between FEV 1 /FVC ratio and RV parameters (Table 5, e-Table 3 ).
Additional Analyses
There was no evidence of effect modifi cation by sex, race or ethnic group, or obesity (all P . .23 for interaction). Associations between percent emphysema and RV measures were similar when percent emphysema in lung core, peel, and upper-lobe regions were used as independent variables (e-Tables 4-6). Effect modifi cation by smoking history was also present (eg, P 5 .021 for RV end-diastolic volume), and results stratifi ed by pack-years of smoking yielded results similar to those stratifi ed by smoking status (e -Fig 1, e- Table 7) . Results were similar when a 2 950 threshold was used to defi ne percent emphysema (e- Table 8 ) and when we considered individuals with no restrictive ventilatory defect on spirometry (e- Table 9 ).
Discussion
Percent emphysema was inversely associated with RV end-diastolic volume, stroke volume, and mass, independent of major confounders in this large, population-based cohort free of clinical cardiovascular disease. Associations varied according to smoking status and were of greater magnitude among ever smokers compared with never smokers. Relative to previously observed decrements in LV volumes and mass, percent emphysema was associated with higher RV end-diastolic volume and RV cardiac output in current smokers, lower RV end-diastolic volume in former smokers, and similar decrements in RV and LV end-diastolic volumes in never smokers.
These fi ndings, along with the previously reported large decrement in LV end-diastolic volume with emphysema, 8 suggest that greater percent emphysema may lead to reduced fi lling of the right ventricle and reduced cardiac output (with reduced pulmonary blood fl ow). In fact, there was indirect evidence of increased RV afterload only among current smokers (ie, large RV end-diastolic volume and greater RV cardiac output relative to LV parameters, the latter presumably due to regurgitant fl ow into the low-pressure vena cava), which was mild (ie, no accompanying increase in RV mass ). The underlying mechanisms of these fi ndings may include destruction of the pulmonary vascular bed in emphysema related to apoptosis of the pulmonary endothelium, 15, 16 endothelial dysfunction 17 or hypercoagulability, 18 a reduction in pulmonary blood fl ow and LV cardiac output, and an increase in pulmonary vascular resistance.
In addition, there may be a direct effect of hyperinfl ation and unloading of both ventricles, particularly among never and former smokers. 19, 20 Hyperinfl ation of the lungs has two principal causes: hyperexpansion of the chest due to emphysema-related loss of elastic recoil and increased intrathoracic pressure (ie, intrinsic positive end-expiratory pressure) due to gas trapping and airfl ow obstruction. Hyperexpansion due to loss of elastic recoil may reduce venous return to the Adjusted for age, weight, height, sex, race/ethnicity, cigarettes per day (current smokers only), pack-y of smoking (current and former smokers only), glucose, diabetes (physician diagnosis or treatment), systolic and diastolic BP, hypertension (physician diagnosis or treatment), educational attainment, fi brinogen, and C-reactive protein, and CT scanner type and tube current in milliamperes. See Table 2 right ventricle and left ventricle because of cardiac rotation and distortions in the systemic and pulmonary vascular structure, respectively. Hyperinfl ation and gas trapping due to intrinsic positive end-expiratory pressure may impair cardiac fi lling by reduced venous return to the thorax 19 and by direct compression of the heart and pulmonary vessels, 21 increasing end-diastolic stiffness of the right ventricle and increasing pulmonary arteriovenous pressure gradients, as has been suggested previously in moderate-severe COPD. 19, 20 Although intrathoracic pressure was not measured (and was infeasible) in this large epidemiologic study, the former mechanism (hyperinfl ation and gas trapping) appears a more likely explanation for our fi ndings in most of the sample, given that associations were predominantly observed with percent emphysema rather than airfl ow obstruction. 22 Reduced LV preload due to chronic thromboembolic pulmonary hypertension causes a reduction in LV mass and ventricular atrophy. 23 Our observations could also be consistent with a similar off-loading of the right ventricle from reduced systemic venous return from emphysema-related hyperinfl ation.
Among current smokers, percent emphysema was positively associated with greater RV end-diastolic volume and less of a reduction in RV cardiac output after adjustment for LV end-diastolic volume. This fi nding suggests that increased RV afterload in early, mostly subclinical, emphysema occurs predominantly in current smokers.
Alternatively, biologic aging contributes to lung function decline (approximately 20-25 mL/y in nonsmokers) and to alterations in LV and RV structure and function. 24, 25 It is well known that emphysema occurs with age, in addition to occurring with smok ing. In addition, percent emphysema was associated with decreasing LV volumes in never smokers. 8 Therefore, the links between radiologic emphysema and RV morphology may also refl ect biologic aging.
Study Limitations
This study has several potential limitations. Smoking may be an important confounder, and former smokers had higher percent emphysema than did current smokers. Previous studies have shown similar results, 8, 22, [26] [27] likely because infl ammatory cell infi ltration and mucus from current smoking make the lung appear denser (ie, lower percent emphysema). To address this limitation, we adjusted all analyses for cigarettes smoked per day. In addition, we performed sensitivity analyses controlling for cotinine level (in the Figure 2 . Relationship between RV end-diastolic volume and % emphysema across smoking categories. Models were adjusted for age, weight, height, sex, race/ethnicity, CT scanner type and tube current in milliamperes, cigarettes per day (only current smokers), pack-y of smoking (only current and former smokers), glucose, diabetes (physician diagnosis or treatment), systolic and diastolic and left atrial volumes, and hypoxemia and pulmonary artery pressures were not available.
Conclusions
In conclusion, percent emphysema was inversely associated with RV end-diastolic volume, stroke volume, and mass, independent of major confounders in this large, population-based cohort. Associations differed from those observed for the left ventricle and varied according to smoking status and severity, which suggests that several potential mechanisms underlie cardiopulmonary interactions in a community-based population.
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